English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
Imatinib-induced hypogammaglobulinemia in children and adolescents with chronic myeloid leukemia
Imatinib-induced hypogammaglobulinemia in children and adolescents with chronic myeloid leukemia
Totadri S et al. Pediatr Hematol Onco, May 2020 (epub ahead of print)
Vaccination with live attenuated vaccines in four children with chronic myeloid leukemia while on imatinib treatment
Vaccination with live attenuated vaccines in four children with chronic myeloid leukemia while on imatinib treatment
Bettoni da Cunha-Riehm C et al. Front Immunol, April 2020 - open access publication
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukemia
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukemia
Giona F et al. Br J Hematol, February 2020 (epub ahead of print)
Experience with ponatinib in paediatric patients with leukaemia
Experience with ponatinib in paediatric patients with leukaemia
Rossoff J et al. Br J Hematol, January 2020 (epub ahead of print)
Pharmacokinetics of nilotinib in pediatric patients with Philadelphia Chromosome-positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia or acute lymphoblastic leukemia
Hijiya N et al. Clin Cancer Res, February 2020 - open access publication
